Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Funny, I am as well. Lots of folks are. Things are magic here.
Easy to cut, copy, paste so I will stick with cited and solid DD.
I'm PCTL Long, sitting on money made, nibbling on sweeties
at/near 1 Euro cent. Once contracts are inked, time to chase.
GLTU. Good luck to PCTL Longs!
O&G, AG, H/C, F/S, etc.
Here's to 2022,
2023, etc!
$PCTL
Nope. A user maybe? Otherwise, please cite proof to support such.
I don't need coddling. I sit on money made, look ahead, smile wide.
I remain PCTL Long and strong, positive and patient, hold tight for
catalysts being worked into deals. Still time to grab some sweeties.
GL PCTL shareholders!
Here's to greener
times, revs!
Warmer
here!
$PCTL
Dear TCaine
We are scientists and analysts commissioned to do a Due Diligence on this TUTUM North Tees HOCL program. We deal in facts and figures. It appears a lot of 'creative' material has been circulated that needs reviewing and assessing. Procurement by a Public Entity such as the UK NHS follows strict protocols. It would be very unwise to attempt to deviate from mandated procedures. Open competition follows proven EU & UK Tendering stages called PreQualification Questionnaires (PQQ's) and then Invitation To Tender (ITT's) therefore competitors equally have the opportunity to make detailed counter-offers. There are no Monopolies as a result. No-one can predict or make promises about possible UK & EU end-results until that individual tendering process is completed and a final decision is made by that buying agency. Even then there is a 2 week stand-off period allowing counter-challenge to the chosen winner. There are 219 UK NHS Trusts and 10 UK Ambulance Trusts which makes cross-marketing a seriously challenging process. Success in one doesn't result in any others buying anything.
Yes, in the last podcast they said they would be scaling back to every quarter.
Yes indeed cuggegrosse promised us monthly podcasts.
Did they actual make a promise of monthly podcasts? I don't recall that being officially stated or "promised", although they did establish a pattern of monthly podcasts for a while. Even if they did make that promise, they did do it for about 6 months or so, perhaps they evaluated and decided to change. Nothing wrong with that.
I did notice that the last podcast was referred to a quarterly podcast, it seems to me that the plan going forward is to hear from Art on a quarterly basis after filings.
Makes sense, and lines up with common practice, many companies hold a conference call or podcast to discuss quarterly reports.
Dear snow
Let's look at the processes behind new concept adoption. Well before COVID every nation has some form of hygiene and disinfection program in-place with authorized products. The UK NHS has over 200 authorized disinfectants on their Procurement lists, five being HOCL from various sources both UK and EU. One prime UK supplier is Aqualution. Once listed each of the numerous UKI NHS Trusts can make their own individual purchase decisions, and have done during the pandemic, purchasing $millions worth of diverse hygiene related products. TUTUM is a late starter and is viewed just another HOCL bit very cleverly they tied up with one single NHS Trust in North Tees. That trust as a commercial division that is allied to TUTUM to market Pathisol and if possible, the PCT HOCL machinery. In the past two years very little progress has been made apart from an impressive website and the slowly developing relationship with that single NHS Trust commercial arm. Preliminary HOCL trials took place over a few weeks giving encouraging results however any generic HOCL @ 500ppm would have give identical results. Now, with those initial statistics the NHS Trust allowed a multi-week live trial in one North Tees hospital, the results to be recorded, analyzed and then published. Pathisol is the product being tested however, please remember that this is a generic HOCL therefore once that individual Trust approves use of 500ppm HOCL then the opportunity opens for all other HOCL providers, including those that supply HOCL generation machines, to offer counter-bids, some being lease and some outright purchase. There are some very competitive prices for HOCL generators far better that the aged technologies PCT use, plus other HOCL's are more long-term stable. It is mandated that any NHS Trust that decides to commit to over £ 20k purchases must open a Tender process and assess all viable options. Even if TUTUM/Pathisol passed a in-use test process that is not a guarantee they would win business, as that NHS Trust and all others must seek best Value For Money any any attempt to evade that process would see HOCL competitors open legal challenges seeking fair play. Even if North Tees adopted Pathisol and the PCT machine, then TUTUM's really hard work begins to sell to all the other UK NHS Trusts, which would take TUTUM well into 2023 & 2024 as UK Fiscal Year budgets run end-March therefore votes for spend would fall in FY 2023-24 and not this FY 2022-23. Parallel to any TUTUM endeavours every single Trust would be bombarded by powerful HOCL competitors waging price wars and technology advantages, with solid supply chain promises and backup, and this is where the debt PCT carries would be used as a weapon against them, as underfunded, the risk of PCTL future collapse is very real. Other HOCL suppliers are well funded and technologically ahead. The only way TUTUM could resolve this real risk to their profile and credibility is to drop working with PCT and find another more advanced HOCL machine supplier. TUTUM could still call the product Pathisol, but unconnected with PCTL. The White Paper would signal the start of commercial warfare that will then persist for years to come, plus many NHS Trusts will just ignore North Tees and Pathisol and carry on buying their current products. There are absolutely NO guarantees any SIGNIFICANT sales will occur.
The same rules apply to all EU states. To successfully compete in this Game of Thrones TUTUM needs serious funding to extensively market both Pathisol and a HOCL generating device in both UK and EU. After COVID struck virtually every US cruise ship and many other 'flags' adopted on-board HOCL generation,as sea water being salt rich is the ideal source medium, and that is why so many top class competitive HOCL generators exist today. There are very markets where anyone has any monopoly, unless they have a unique process or technology backed by Patents and solid IPR.
Didnt PCT promise monthly podcasts?
I believe the last one was in May!!
Another promise not kept
$PCTL no but contracts are coming from Nigeria!!
Is it coming from Nigeria?
If PCTL doesnt close above $0.013 today, its gonna create a big problem
MrBiocide I live in a country not far from the UK. It is a small, but wealthy, country on the continent.
I find your information interesting although limited. It might be wise for you to purchase some PCTL
while it sits at/near 1 Euro cent. Several catalysts are being worked now and readied for contracts.
Looking forward to some big news in this second half of 2022, next year...and beyond. I hold PCTL
Long and sit on money made. Looking for more, and remain positive and patient. GL to you and all.
$PCTL
That didnt take long, back to sub-penny lol
MrBiocide I live in a country not far from the UK. I find your information very interesting. It presents a picture that is totally different from the one that has been presented here about PCTL. Up to now I have had the impression that PCTL would have a virtual monopoly regarding hospitals under the NHS umbrella regardin the use of HOCL and the hardware used to spray it in the hospital rooms. There have also been references to thousands of other health institutions where one could expect the Analyzer had a good chances of being taken into use. The impression has been given that the UK could be expected to be a very important source of income for PCTL. This impression has faded somewhat though over the years as nothing seems tp have happened when it comes to sales to the NHS.
LOL the 1 week daily avg. is 523,463 more buys than that already!!
Tiny buying fizzled out, as usual
Now the slow, but sure, return to sub penny? lol
$PCTL smart strong hands loading!!
PCTL like ALL the publicly-traded corporations issues/sells shares.
I am PCTL Long, sit on money made, and look forward to the future.
GL shareholders!
Summertime
is gonna
sizzle.
$PCTL
Imagine an airline using this company’s product in their airplanes. Sir, your seat will be dry in 10 minutes. Chuckles What a sham this pos is.
The “white paper” is in the trash next to the Holcomb blacked out paper. This scam sells one thing! Shares, Period
No need to bluff when you have the real deal.
Correct! Thanks for the DD
While up is good, the fact that it's trended so low over the last couple of years and continues trending lower, and can't close and a cent, despite all the wonderful news (not), speaks volumes about the real prospects for pctl and its shareholders.
This company is essentially toast. It's finding its way back to pre covid price levels, which in all honesty, is right where it belongs. The only thing that boosted it was the covid pump. Now there's nothing. Oil and gas is a pipe dream unfortunately.
We need the ASK to move up.
If they'd ask nicely, the buyers will come.
TGC
I hope you're wrong???? UK/Nigeria
Always willing to keep to the facts.
Fairy tales help no one! Aesop is a poster?... lol for real!
Have a nice evening.
Catch up manana... or so
PCTL close today Up AGAIN
PCTL
PCT LTD COM
$0.0099+0.0006 (+6.45%)
Just a hair over million in volume!
To you as well Godough. The poster in question lines fairy tales. I like keeping it honest as well. Nigeria is most likely the new UK. Full of empty promise.
I heard D.Eagle is bringing a oil rig up the old Mississippi to help out....Employee of the month..I can see it!!
Thanks for your post. I've been telling them this for over two years. They'll figure it out eventually. Pct is a small fish with weak fundamentals. Further more they've given up their ownership stake in pct Europe. They're simply irrelevant.
An update was just posted today on LinkedIn, the testing is in week 6.
Also, NTH Solutions just put out a new article on the test process
https://nthsolutions.co.uk/the-data-gathering-culturing-and-tracing-our-samples/
The testing is being conducted by Teesside University, looks to be pretty thorough and reputable to me.
Thank you for the reply. So what is going on with the latest round of testing that they announced about a month ago? Is this legit and do you have any sense of how it is going?
Also, do any competitors have the delivery / tracking system that our does?
Nah ..
PCT's got Lawyers for Litigation.
PCT's got Lawyers for SEC compliance.
PCT's got lawyers for contract issues.
PCT's got Lawyers!
Yes
Regarding all the paragraphs proceeding,
With GG leading the charge……..
Flexing his muscles all the way!
I’m not up the creek!
Just was wondering when the big news was gonna hit.
Great post.
Can you indicate what pctl's new demand is?
When is the next batch of Grassy Creek test results due?
You raise some interesting questions and concerns. I have been following the UK developments for quite a while myself. My stance on the UK has been to keep it as a maybe it happens, maybe it doesn't happen category. PCT's CFO said they were keeping the revenue potential out of their projections, with the stance that maybe it happens, maybe it doesn't, so I have taken the same stance.
I do not claim to be an expert on getting things going in the UK, but I do have experience setting up new business in other countries around the world. I know that every market/system has its differences and its challenges. So I can relate to the concerns you raise about entering into the UK market. The one thing I will point out though is the quality of the Tutum team. They have some highly experienced and qualified people on board. And the NTH Solutions partnership looks to be quite legitimate to me, with verified and legitimate connections. But as you have articulated, there certainly are many hurdles to be cleared and challenges to be met.
And as I already said, for PCT, the UK is a bonus that could be great if it develops as hoped. There are multiple other "irons in the fire" that are much more directly under PCT's control that I and many other shareholders believe will determine the future of the company.
Appreciate all the insight.
It's too bad PCT couldnt offer its shareholders the equivalent insight.
Perhaps they just dont know any better or maybe they do and decided to clam up.
Your thoughts?
$PCTL that may be an explanation by your standards but it will be settled by the Court & not public opinion. PCT LTD is obviously is in disagreement with Auctus.
We shall see who prevails??
PCT, Ltd. v. Auctus Fund LLC
In December of 2021, Auctus Fund fraudulently exercised the Warrant,
despite such Warrant being resolved pursuant to the Settlement Agreement, to obtain
2,539,999 shares of PCT common stock, with a fair market value of approximately
$65,000.00, and has attempted to exercise that same Warrant to obtain an additional
40,145,693 shares of PCT common stock, with a fair market value of approximately
$1,000,000.00.
40. By reason of the foregoing, PCT is entitled to an award of compensatory
and consequential damages as set forth above, which relief is well in excess of a value
of $75,000.00.
71. Prior to its presentation of the Warrant to Standard Registrar, the Warrant
had been resolved and released pursuant to the Settlement Agreement for which
Auctus Fund was already paid $145,000.00 and received 8,000,000 shares of PCT
common stock valued at approximately $200,000.00.
72. Auctus Fund took the $145,000.00 and 8,000,000 shares of PCT common
stock with the intention of breaching its obligations under the Settlement Agreement.
73. Auctus Fund has therefore unlawfully benefited from and has been
unjustly enriched by its receipt of not only the 2,539,999 shares of PCT common stock,
but also the $145,000.00 and 8,000,000 shares of PCT common stock.
74. By reason of the foregoing, PCT is entitled to damages in an amount to be
determined at trial, plus interest thereon, which damages are well in excess of a value
of $75,000.00.
76. As explained herein, PCT and Auctus Fund entered into the Settlement
Agreement to resolve all disputes, claims, rights, demands, liabilities, obligations and the like between and among them, including, without limitation, the Warrant
Those Privately Leaked items are highly suspect! Why would they leak such information to an individual??
Thanks for for the chat!
Hearsay, AKA invented.
Best of luck TGC.
Dear Mugwumps88
My team and I were there, talking with Infection Control delegates and other exhibitors. Having worked these last 35 years in this subject at UK National Government level, we do not need to resort to BS. It seems the whole PCT/TUTUM and UK NHS story is very well scripted to appear to be much better than it actually is. Pathisol is just another HOCL of many, and will face serious challenges once NHS and other tenders are published. Due to post-COVID semi-Recession any NHS contract/s to buy HOCL machines and liquids will be fiercely contested as suppliers will resort to every dirty trick in the book. PCL's weak finances and fierce competition from far more powerful and competent suppliers will be a real challenge. If TUTUM try to bluff their NHS inside-track position and then are exposed, proven to be false, they and Pathisol are game over. Here in the UK open-tendering is mandatory with ITT & PQQ's eliminating lesser suppliers. The same applies to all EU tenders. It will be very interesting to see how this story unfolds. Any 'white-paper' will be closely scrutinized. If there in any attempt to bluff will have commercially fatal consequences to them and those partnering them. Too many people are now watching.....
I'd suggest that everyone read the PCT Court filing, and the amended filing. I've read them both in their entirety, and then Dismissed the speculative nonsense (shit) posted here.
The speculative shit I read here. Ridiculous.
Already been explained... Sheesh!!
Followers
|
604
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
200741
|
Created
|
05/29/18
|
Type
|
Free
|
Moderators jimr1717 thegreencandle |
Our products (equipment) and solutions (Hydrolyte® and Catholyte Free®) are designed to take an environmentally conscious approach to combat the spread of infectious disease in the healthcare and Cleaning/Sanitation industries, as well as contributing to the sustainability of global natural resources in the agriculture markets.
Our technology produces an effective pre-determined PPM Hypochlorous Acid (HOCl) solution that is created through an electrolytic process called Electro-Chemical Activation (ECA). It occurs by temporarily changing the makeup of water, bypassing weak salt brine through an electrolytic cell, and temporarily changing the properties of the salt water into a powerful oxidizing agent, exhibiting highly effective antimicrobial properties.
Many billions of dollars a year are spent by individuals, organizations, and the health care system to treat people who get infectious diseases caused by microbes including bacteria, viruses, and fungi. With the advent of adaptive and ever more dangerous microorganisms called “superbugs”, the danger of acquiring life-threatening infections is real and growing. This danger affects everyone anytime they are in space where people gather, any microbe contaminating that space is a possible source of infection. With American’s spending 20 or more hours a day indoors, much of it in spaces that are not cleaned and sanitized/ disinfected properly, the threat of infection is constant, growing, and dangerous, particularly to our vulnerable populations of the very young, elderly and infirm.
Infectious diseases were associated with an economic burden of over $120 billion in the U.S. in 2014. Antibiotic-resistant infections cost Americans $20 billion in direct medical costs and $35 billion in lost productivity in 2014. A particularly acute problem is Hospital Acquired Infections (HAIs) which are increasingly hard to kill or treat effectively. As a result, doctors struggle to contain, fight and cure increasingly antibiotic-resistant infections such as MRSA, and C. Diff. The more antibiotics, medicines, pesticides and disinfectants are used to kill them, the quicker the microorganisms adapt, becoming ever stronger and more drug-resistant. Researchers estimate that, if the U.S. could reduce the number of hospital-acquired infections by 20%, healthcare providers would save nearly $7 billion per year. Insurance companies are beginning to deny coverage for treatment of HAIs, forcing hospitals to self-insure. This will create an immense financial and risk-management burden on hospitals, long-term medical, rehabilitation, and assisted living facilities.
Overcoming the problem of microbial contamination and infectious disease can be straightforward. It requires proper products, equipment, protocols, education, and training for comprehensive and reliable cleaning, sanitizing, and disinfecting solutions.PCT Corp. offers these with its comprehensive “Green Cleaning” and Infection Control Systems. Infectious microbes cannot develop resistance to the cleaning and sanitizing products PCT Corp. uses and they are much less toxic to humans or pets than traditional agents such as bleach and ammonia.
The products are used through a commercially-ready, patented, integrated product and technology solution for total facility cleaning and sanitizing. This system and solution, The PCT Annihilyzer® Infection Control System, was specifically designed for use in hospitals, assisted living and nursing homes, and other large facilities. In various configurations, the solution system can be deployed in urgent care centers, medical, dental, and veterinary practices, and other health care facilities. A complete and custom turn-key cleaning, sanitizing, and disinfection program solution can be provided to each facility. It is also adaptable to deployment in schools, prisons, hotels, and many other facilities.
PCT has launched a major marketing and sales effort in the hospital facilities market and The PCT Annihilyzer® System has now been deployed in several hospitals in the eastern U.S.
Ticker Symbol:PCTL
4235 Commerce Street. Little River, SC 29566
Phone: 843-390-7900 Fax: 843-390-2327
Email: admin@pctl.com
***Last Reported Share Structure***
As of 12/30/21
Authorized: 1,000,000,000
Outstanding Shares: 790,924,690
Float: 525,421,556
https://www.otcmarkets.com/stock/PCTL/overview
https://www.otcmarkets.com/stock/PCTL/profile
https://www.otcmarkets.com/stock/PCTL/quote
https://www.otcmarkets.com/stock/PCTL/disclosure
Nano-Catholyte treated oil on its way to an oil refinery
Hospital-acquired infections (HAI) — also known as a nosocomial infection — is an infection that is contracted from the environment or staff of a healthcare facility. It can be spread in the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings. In the United States, the Centers for Disease Control and Prevention estimated roughly 1.7 million hospital-associated infections, from all types of microorganisms, including bacteria and fungi combined, cause or contribute to 99,000 deaths each year.
Our goal is to provide solutions to this issue, by outfitting a healthcare setting with the technology and guidance needed to effectively get the job done - all through a dedicated partnership to prevent and eradicate the spread of infectious disease.
Oil and Gas:
Waste Water Treatment
Our system helps to decontaminate “frac” water for reuse in the fracking process, saving the industry millions of dollars and preserving the world’s water supply. Some of the many benefits of our system/process include: Elimination of highly toxic chemicals currently used for decontamination, reduced negative environmental impact, reduced recovery costs and potentially opening new areas for oil and gas retrieval.
Turning “Sour” Crude Oil to “Sweet”
In other areas in the gas and oil industry that presents a challenge is in treating existing wells for the presence of H2S of hydrogen sulfide. H2S is a large and growing problem in the industry, due to its continued introduction of bacteria in the fracking process. H2S causes increased production costs. Our solutions reduce those costs and reduce the environmental impact.
Agriculture:
In the agriculture world, through USDA grants and multiple studies by universities around the world, Hypochlorous acid solutions have been tested and proven effective against yield-reducing crop pathogens in post-harvest applications to include sanitizing at point of harvest, point of packing and points of sale.
We are hoping to help stop these crop-devastating pathogens with our hypochlorous solutions that are known to be environmentally responsible and designed to improve and maintain crop yields, to produce a healthier overall harvest.
School Systems:
Dedicated to the success of students, schools are faced with a multitude of challenges to reach their goal of providing a solid education and an environment for healthy growth. To add to the list of responsibilities of school administrators, the battle of keeping absenteeism down, preventing the spread of infectious disease and keeping a clean environment bears a heavy load. Not only are the traditional cleaning products losing their effectiveness - thus allowing drug/antimicrobial resistant pathogens to wreak havoc - they are also polluting the indoor air with volatile organic compounds (VOCs) that are known to cause respiratory-related issues, headaches and other ailments.
By providing daycare facilities, school systems and universities with a better alternative to poisonous, caustic chemical cleaning/antimicrobial agents, we’re providing a more productive environment. Not only are you killing germs with a product that eradicates them completely - keeping them from becoming resistant - you’re doing so with a product that doesn’t cause harm to the user, students or faculty.
Hotel and Tourism:
Similar to the healthcare environment, the hotel and tourism industry (i.e resorts, airports, cruise ships, etc.) are subject to communicable diseases. In the healthcare market, they are referred to as Hospital-Acquired Infections/Healthcare-Associated Infections (HAIs) and in the hotel and tourism industry, they are known as Community-Acquired Infections. With as many different people traveling through these areas, from all sorts of countries and carrying various types of ailments or pathogens with them, consider the potential for an uncontrollable spread of these germs.
Outbreaks are typically caused by lack of proper processes and/or a failing product. Our ECA technology is designed to help anyone in the industry to get a grip on the issue and succeed at their main goal: providing an awesome experience for their guests.
Food Service/Production:
Our sanitizer strength solution meets the requirement of the FDA and USDA, to be a non-rinse sanitizing agent. In the world of dealing with food, why not use a product that actually kills food-borne pathogens - without containing any toxic chemicals that would harm the quality of the product?
Whether you’re dealing with meat, poultry or just need to maintain a facility’s defense against Salmonella/E. coli, contact us about using our solutions
Forget harsh, toxic chemicals. Our process only requires salt, water and electricity to produce two products –a chlorine-based antimicrobial agent and an excellent degreasing cleaner.
Our technology produces an effective variable PPM hypochlorous acid solution that is created through an electrolytic process called Electro-Chemical Activation (ECA). It occurs by temporarily modifying the properties of water, by passing weak salt brine through an electrolytic cell and temporarily changing the properties of the salt water into a powerful oxidizing agent exhibiting highly effective antimicrobial properties.
Catholyte or sodium hydroxide, is an aqueous solution that is the natural byproduct of the electrolysis process, and is used to reduce microbe contamination and soil loads that can harbor germs on hard surfaces.
Catholyte is also a very effective degreaser and is a great option to safely clean floors without hazardous fumes, thus improving indoor air quality.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |